Abstract: The present disclosure provides a substrate-enhanced comparator and electronic device, the comparator including: a cross-coupled latch, for connecting input signals to the gate of a cross-coupled MOS transistor to form a first input of the latch; output buffers, connected to the cross-coupled latch for amplifying output signals of the latch; AC couplers, connected to the output buffers for receiving and amplifying the output signals of the latch, coupling the output signals to substrates of the cross-coupled MOS transistors to form second inputs of the latch. The cross-coupled latch is also for output signal regenerative latching based on input signals sampled at the first inputs and input signals sampled at the second inputs. The present disclosure introduces additional substrate inputs to the cross-coupled structure of the conventional latch as the second inputs of the latch.

Abstract: The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.

Abstract: The present disclosure proposes a modeling method and apparatus for diagnosing an ophthalmic disease based on artificial intelligence, and a storage medium. The modeling method includes: establishing a data collection of ophthalmic images and a data collection of non-image ophthalmic disease diagnosis questionnaires; training a first neural network model by employing the data collection of the ophthalmic images to obtain a first classification model; training a second classification model by employing the data collection of non-image ophthalmic disease diagnosis questionnaires; and merging the first classification model and the second classification model to obtain a target classification network model, in which, a test result outputted by the target classification network model is used as a diagnosis result of the ophthalmic disease.

Abstract: The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.

Abstract: The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.

Abstract: Examples of the present disclosure describe systems and methods for enterprise search that leverage periodically updated user context of an enterprise user for intent understanding and treat a search session as a dialog between the user and a digital assistant to allow multi-modal interaction. For example, a query input by the user may be received from a client application having search functionality and an integrated assistant. A current state of the user context may be leveraged to understand the query. Based on the understanding, one or more responsive entities may be retrieved from an enterprise search index as results. Based on the results, a response may be generated that includes the results and a prompt to cause the user to further refine the query and/or provide feedback. The response may be provided to the client application for output as part of a search session dialog between the user and assistant.

Abstract: Examples of the present disclosure describe systems and methods for generating multiple semantic hypotheses for search query intent understanding. In aspects, a search query may be received by a query analysis component associated with a search system. The query analysis component may be used to evaluate the search query for ambiguity in the domain, intent, and/or slot(s) of the search query. A set of hypotheses representing for one or more combinations of the domain, intent, and/or slot(s) of the search query may be generated. The set of hypotheses may be scored and/or ranked. Based on the scores/ranks, one or more of the hypotheses in the set of hypotheses may be provided to a user and/or one or more processing components accessible to the search system.

Abstract: The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.

Abstract: The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.

Abstract: The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.

Abstract: The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.

Abstract: A method, an apparatus and a system for information retrieval are provided. The method for information retrieval may comprise: receiving a query in a natural language form from a user (210); extracting a plurality of feature vectors from the query based on a plurality of knowledge entries in a knowledge base associated with the user and a built-in featurization source, one feature vector per knowledge entry (220); obtaining, with a pre-trained language understanding model, a plurality of language understanding results based on the plurality of feature vectors (230); and selecting a knowledge entry corresponding to the query among the plurality of entries based on the plurality of language understanding results (240). The method may extract more features and combine information retrieval and language understanding in one shot to improve efficiency.

Abstract: The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.

Abstract: The present disclosure proposes a modeling method and apparatus for diagnosing an ophthalmic disease based on artificial intelligence, and a storage medium. The modeling method includes: establishing a data collection of ophthalmic images and a data collection of non-image ophthalmic disease diagnosis questionnaires; training a first neural network model by employing the data collection of the ophthalmic images to obtain a first classification model; training a second classification model by employing the data collection of non-image ophthalmic disease diagnosis questionnaires; and merging the first classification model and the second classification model to obtain a target classification network model, in which, a test result outputted by the target classification network model is used as a diagnosis result of the ophthalmic disease.

Abstract: The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.

Abstract: The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.

Abstract: The present disclosure discloses a method and a device for loading a webpage. The method for loading a webpage includes: sending a webpage request message to a server; receiving an initial webpage of the webpage returned from the server, the initial webpage including an agent; sending a WebSocket connection request message to the server through the agent, to establish a WebSocket connection with the server; sending a page component request message of the webpage to the server based on the WebSocket connection, to load page component of the webpage; receiving the page components of the webpage returned from the server based on the WebSocket connection; and creating the page components at corresponding positions in the initial webpage.

Abstract: A method, an apparatus and a system for information retrieval are provided. The method for information retrieval may comprise: receiving a query in a natural language form from a user (210); extracting a plurality of feature vectors from the query based on a plurality of knowledge entries in a knowledge base associated with the user and a built-in featurization source, one feature vector per knowledge entry (220); obtaining, with a pre-trained language understanding model, a plurality of language understanding results based on the plurality of feature vectors (230); and selecting a knowledge entry corresponding to the query among the plurality of entries based on the plurality of language understanding results (240). The method may extract more features and combine information retrieval and language understanding in one shot to improve efficiency.

Abstract: The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.

Abstract: A power supply circuit coupled to a power source for providing electronic energy to a workload includes a first switch, a control circuit, a first diode, and a backup power, in which the input of the first switch is coupled to the power source, the output of the first switch is coupled to the workload, the control circuit is coupled to the control terminal of the first switch for determining the state of the power source, the anode of the first diode is coupled to the power source, the cathode of the first diode is coupled to the first terminal of the backup power, the first terminal of the backup power is further coupled to the workload, when the control circuit determines that the power source is in a power-off state, a control signal is applied to the control terminal of the first switch to turn off the first switch.